China Medical & HealthCare Group Limited provided consolidated earnings guidance for the eleven months ended 30 November 2022. For the period, the company group is expected to record a loss attributable to shareholders of the Company ("Net Loss") for the eleven months ended 30 November 2022 which represents (a) an approximately 26% decrease as compared with the Net Loss for the corresponding period in 2021; (b) an approximately 30% to 50% decrease when compared with the Net Loss for the year ended 31 December 2021; but (c) an approximately 20% to 40% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 HKD | 0.00% | 0.00% | -12.50% |
1st Jan change | Capi. | |
---|---|---|
-12.50% | 97.38M | |
-18.96% | 16.46B | |
+3.60% | 12.53B | |
+3.98% | 11.77B | |
+4.28% | 10.13B | |
+27.92% | 8.59B | |
-6.04% | 7.42B | |
+6.17% | 6.73B | |
+8.77% | 6.48B | |
-2.79% | 4.35B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022